Table 2.
Final diagnosis in all patients (n=93) | Number of cases, n (%) | Overall yield, n (%) | Cyt (+) CB (−), n (%) | Cyt (−)* CB (+), n (%) | Cyt (+) CB (+), n (%) | Cyt (−) CB (−), n (%) |
---|---|---|---|---|---|---|
Malignancy | 56 (60) | 51 (91) | 5 (9) | 1 (2) | 45 (80) | 5 (9) |
Lung cancer | 50 (54) | 46 (92) | 5 (10) | 1 (2) | 40 (80) | 4 (8) |
Breast cancer | 2 (2) | 0 | 0 | 0 | 2 (100) | 0 |
RCC | 1 (1) | 0 | 0 | 0 | 1 (100) | 0 |
GCT | 1 (1) | 0 | 0 | 0 | 1 (100) | 0 |
MDS | 1 (1) | 0 | 0 | 0 | 0 | 1 (100) |
BC | 1 (1) | 0 | 0 | 0 | 1 (100) | 0 |
Benign diseases | 37 (40) | 26 (70) | 4 (11) | 2 (5) | 20 (54) | 11 (30) |
Tuberculosis | 16 (17) | 13 (81) | 4 (25) | 0 | 9 (64) | 3 (22) |
Sarcoidosis | 14 (15) | 11 (79) | 0 | 2 (14) | 2 (100) | - |
Melioidosis† | 2 (2) | 2 (100) | - | - | 0 | 2 (100) |
NSIP | 2 (2) | 0 | 0 | 0 | 0 | 1 (100) |
Vasculitis | 1 (1) | 0 | 0 | 0 | 0 | 1 (100) |
Silicosis | 1 (1) | 0 | 0 | 0 | 0 | 1 (100) |
Post-TB fibrosis | 1 (1) | 0 | 0 | 0 | ||
Total | 93 (100) | 77 (83) | 9 (10) | 3 (3) | 65 (70) | 16 (17) |
*All cases those are cytology negative but cell block positive constitutes additional yield, †Melioidosis was diagnosed based on microbiological evidence in the aspirate and both cytology and cell block specimen showed necrotic material. N: Total number of study participants, n (%)-number percentage. Cyt (+): Cytology positive, CB (−): Cell block negative, RCC: Renal cell carcinoma, GCT: Germ cell tumor, MDS: Myelodysplastic syndrome, BC: Buccal carcinoma, NSIP: Nonspecific interstitial pneumonitis, TB: Tuberculosis